Affimed signs up to $5bn cancer therapeutics deal with Genentech
German biopharmaceutical firm Affimed has signed a collaboration agreement with Roche unit Genentech for the...
German biopharmaceutical firm Affimed has signed a collaboration agreement with Roche unit Genentech for the...